nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—IL23-mediated signaling events—IL19—type 1 diabetes mellitus	0.0591	0.124	CbGpPWpGaD
Nabumetone—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.0173	0.0331	CcSEcCtD
Nabumetone—Glossitis—Ramipril—type 1 diabetes mellitus	0.0165	0.0315	CcSEcCtD
Nabumetone—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0155	0.0298	CcSEcCtD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—HSD11B2—type 1 diabetes mellitus	0.015	0.0314	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—STAT4—type 1 diabetes mellitus	0.0137	0.0287	CbGpPWpGaD
Nabumetone—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.0125	0.024	CcSEcCtD
Nabumetone—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0124	0.0238	CcSEcCtD
Nabumetone—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.0123	0.0235	CcSEcCtD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—HSD11B2—type 1 diabetes mellitus	0.0119	0.025	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—HBA1—type 1 diabetes mellitus	0.0114	0.0239	CbGpPWpGaD
Nabumetone—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.0114	0.0218	CcSEcCtD
Nabumetone—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.0102	0.0195	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00991	0.019	CcSEcCtD
Nabumetone—Gastritis—Ramipril—type 1 diabetes mellitus	0.00974	0.0187	CcSEcCtD
Nabumetone—Asthma—Ramipril—type 1 diabetes mellitus	0.00952	0.0182	CcSEcCtD
Nabumetone—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00952	0.0182	CcSEcCtD
Nabumetone—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00933	0.0179	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—HBA1—type 1 diabetes mellitus	0.0093	0.0195	CbGpPWpGaD
Nabumetone—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00927	0.0177	CcSEcCtD
Nabumetone—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00927	0.0177	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—FGF21—type 1 diabetes mellitus	0.00884	0.0185	CbGpPWpGaD
Nabumetone—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00876	0.0168	CcSEcCtD
Nabumetone—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00869	0.0166	CcSEcCtD
Nabumetone—Weight increased—Ramipril—type 1 diabetes mellitus	0.00866	0.0166	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00841	0.0161	CcSEcCtD
Nabumetone—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00836	0.016	CcSEcCtD
Nabumetone—Renal failure—Ramipril—type 1 diabetes mellitus	0.00834	0.016	CcSEcCtD
Nabumetone—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00832	0.0159	CcSEcCtD
Nabumetone—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00827	0.0158	CcSEcCtD
Nabumetone—Jaundice—Ramipril—type 1 diabetes mellitus	0.00827	0.0158	CcSEcCtD
Nabumetone—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00792	0.0152	CcSEcCtD
Nabumetone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NOS1—type 1 diabetes mellitus	0.0075	0.0157	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	0.00739	0.0155	CbGpPWpGaD
Nabumetone—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00734	0.0141	CcSEcCtD
Nabumetone—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.0072	0.0138	CcSEcCtD
Nabumetone—PTGS2—Signaling mediated by p38-alpha and p38-beta—DDIT3—type 1 diabetes mellitus	0.00719	0.0151	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—SOD2—type 1 diabetes mellitus	0.00713	0.0149	CbGpPWpGaD
Nabumetone—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0071	0.0136	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—NOS2—type 1 diabetes mellitus	0.00704	0.0147	CbGpPWpGaD
Nabumetone—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.0068	0.013	CcSEcCtD
Nabumetone—Alopecia—Ramipril—type 1 diabetes mellitus	0.00673	0.0129	CcSEcCtD
Nabumetone—Tension—Ramipril—type 1 diabetes mellitus	0.00651	0.0125	CcSEcCtD
Nabumetone—Nervousness—Ramipril—type 1 diabetes mellitus	0.00644	0.0123	CcSEcCtD
Nabumetone—Tremor—Ramipril—type 1 diabetes mellitus	0.00621	0.0119	CcSEcCtD
Nabumetone—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00615	0.0118	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—CAT—type 1 diabetes mellitus	0.00612	0.0128	CbGpPWpGaD
Nabumetone—Agitation—Ramipril—type 1 diabetes mellitus	0.00609	0.0117	CcSEcCtD
Nabumetone—Angioedema—Ramipril—type 1 diabetes mellitus	0.00606	0.0116	CcSEcCtD
Nabumetone—Malaise—Ramipril—type 1 diabetes mellitus	0.00598	0.0114	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—CRP—type 1 diabetes mellitus	0.00597	0.0125	CbGpPWpGaD
Nabumetone—Vertigo—Ramipril—type 1 diabetes mellitus	0.00596	0.0114	CcSEcCtD
Nabumetone—Syncope—Ramipril—type 1 diabetes mellitus	0.00595	0.0114	CcSEcCtD
Nabumetone—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00593	0.0114	CcSEcCtD
Nabumetone—Palpitations—Ramipril—type 1 diabetes mellitus	0.00586	0.0112	CcSEcCtD
Nabumetone—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00583	0.0112	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—SOD2—type 1 diabetes mellitus	0.0058	0.0121	CbGpPWpGaD
Nabumetone—Cough—Ramipril—type 1 diabetes mellitus	0.00579	0.0111	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—TYK2—type 1 diabetes mellitus	0.00577	0.0121	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—AIF1—type 1 diabetes mellitus	0.00575	0.012	CbGpPWpGaD
Nabumetone—Anxiety—Ramipril—type 1 diabetes mellitus	0.00562	0.0108	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IL4—type 1 diabetes mellitus	0.00562	0.0118	CbGpPWpGaD
Nabumetone—Discomfort—Ramipril—type 1 diabetes mellitus	0.00558	0.0107	CcSEcCtD
Nabumetone—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00552	0.0106	CcSEcCtD
Nabumetone—Confusional state—Ramipril—type 1 diabetes mellitus	0.00546	0.0104	CcSEcCtD
Nabumetone—Oedema—Ramipril—type 1 diabetes mellitus	0.00541	0.0104	CcSEcCtD
Nabumetone—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00541	0.0104	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—type 1 diabetes mellitus	0.00541	0.0113	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IFNG—type 1 diabetes mellitus	0.0054	0.0113	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—CRP—type 1 diabetes mellitus	0.00539	0.0113	CbGpPWpGaD
Nabumetone—Shock—Ramipril—type 1 diabetes mellitus	0.00532	0.0102	CcSEcCtD
Nabumetone—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.0053	0.0101	CcSEcCtD
Nabumetone—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00523	0.01	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—CD4—type 1 diabetes mellitus	0.00522	0.0109	CbGpPWpGaD
Nabumetone—Anorexia—Ramipril—type 1 diabetes mellitus	0.00516	0.00988	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—FGF21—type 1 diabetes mellitus	0.005	0.0105	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—INS—type 1 diabetes mellitus	0.00499	0.0105	CbGpPWpGaD
Nabumetone—Insomnia—Ramipril—type 1 diabetes mellitus	0.00489	0.00937	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00486	0.0102	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—CRP—type 1 diabetes mellitus	0.00486	0.0102	CbGpPWpGaD
Nabumetone—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00486	0.0093	CcSEcCtD
Nabumetone—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00482	0.00924	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—IL1B—type 1 diabetes mellitus	0.00482	0.0101	CbGpPWpGaD
Nabumetone—Somnolence—Ramipril—type 1 diabetes mellitus	0.00481	0.00921	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—IL2—type 1 diabetes mellitus	0.0048	0.01	CbGpPWpGaD
Nabumetone—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00476	0.00912	CcSEcCtD
Nabumetone—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0047	0.00901	CcSEcCtD
Nabumetone—Fatigue—Ramipril—type 1 diabetes mellitus	0.00467	0.00893	CcSEcCtD
Nabumetone—Constipation—Ramipril—type 1 diabetes mellitus	0.00463	0.00886	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.00461	0.00965	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—ALB—type 1 diabetes mellitus	0.00458	0.00958	CbGpPWpGaD
Nabumetone—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00446	0.00854	CcSEcCtD
Nabumetone—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00442	0.00847	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—type 1 diabetes mellitus	0.00438	0.00917	CbGpPWpGaD
Nabumetone—Urticaria—Ramipril—type 1 diabetes mellitus	0.0043	0.00823	CcSEcCtD
Nabumetone—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00428	0.00819	CcSEcCtD
Nabumetone—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00428	0.00819	CcSEcCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—CRP—type 1 diabetes mellitus	0.00428	0.00895	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IFNG—type 1 diabetes mellitus	0.00418	0.00874	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—INS—type 1 diabetes mellitus	0.00406	0.0085	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—STAT3—type 1 diabetes mellitus	0.00404	0.00845	CbGpPWpGaD
Nabumetone—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00399	0.00763	CcSEcCtD
Nabumetone—Asthenia—Ramipril—type 1 diabetes mellitus	0.00388	0.00743	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.00386	0.00808	CbGpPWpGaD
Nabumetone—Pruritus—Ramipril—type 1 diabetes mellitus	0.00383	0.00733	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—IL1B—type 1 diabetes mellitus	0.00373	0.0078	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—ALB—type 1 diabetes mellitus	0.00372	0.0078	CbGpPWpGaD
Nabumetone—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.0037	0.00709	CcSEcCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—type 1 diabetes mellitus	0.00363	0.00759	CbGpPWpGaD
Nabumetone—Dizziness—Ramipril—type 1 diabetes mellitus	0.00358	0.00685	CcSEcCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—type 1 diabetes mellitus	0.00353	0.00738	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—TNF—type 1 diabetes mellitus	0.0035	0.00732	CbGpPWpGaD
Nabumetone—Vomiting—Ramipril—type 1 diabetes mellitus	0.00344	0.00659	CcSEcCtD
Nabumetone—Rash—Ramipril—type 1 diabetes mellitus	0.00341	0.00653	CcSEcCtD
Nabumetone—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00341	0.00653	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IFNG—type 1 diabetes mellitus	0.0034	0.00711	CbGpPWpGaD
Nabumetone—Headache—Ramipril—type 1 diabetes mellitus	0.00339	0.00649	CcSEcCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—type 1 diabetes mellitus	0.00337	0.00705	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—type 1 diabetes mellitus	0.00323	0.00676	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.00323	0.00676	CbGpPWpGaD
Nabumetone—Nausea—Ramipril—type 1 diabetes mellitus	0.00321	0.00615	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IL1B—type 1 diabetes mellitus	0.00303	0.00635	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	0.00302	0.00633	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL2—type 1 diabetes mellitus	0.00302	0.00632	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—type 1 diabetes mellitus	0.00302	0.00631	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.00296	0.00619	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	0.00287	0.006	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PRKCQ—type 1 diabetes mellitus	0.00282	0.00591	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL6—type 1 diabetes mellitus	0.00282	0.0059	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—CD4—type 1 diabetes mellitus	0.00271	0.00567	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—TNF—type 1 diabetes mellitus	0.0027	0.00566	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.0027	0.00565	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—type 1 diabetes mellitus	0.00263	0.0055	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.00252	0.00528	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1R1—type 1 diabetes mellitus	0.0025	0.00524	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—TNF—type 1 diabetes mellitus	0.00244	0.0051	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.00243	0.00508	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.00241	0.00504	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	0.0024	0.00502	CbGpPWpGaD
Nabumetone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—type 1 diabetes mellitus	0.00239	0.00501	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—type 1 diabetes mellitus	0.00234	0.00491	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—type 1 diabetes mellitus	0.00228	0.00477	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—E2F1—type 1 diabetes mellitus	0.00227	0.00475	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—TNF—type 1 diabetes mellitus	0.0022	0.0046	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IL6—type 1 diabetes mellitus	0.00218	0.00457	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—type 1 diabetes mellitus	0.00218	0.00456	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—type 1 diabetes mellitus	0.00213	0.00446	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—LGALS3—type 1 diabetes mellitus	0.00211	0.00442	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—type 1 diabetes mellitus	0.00209	0.00437	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00199	0.00417	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—IL6—type 1 diabetes mellitus	0.00197	0.00412	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—TNF—type 1 diabetes mellitus	0.00194	0.00405	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—type 1 diabetes mellitus	0.00189	0.00397	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.00189	0.00395	CbGpPWpGaD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00186	0.00389	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—type 1 diabetes mellitus	0.00185	0.00387	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL6—type 1 diabetes mellitus	0.00178	0.00372	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.00175	0.00366	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00173	0.00361	CbGpPWpGaD
Nabumetone—CYP1A2—Estrogen Receptor Pathway—STAT3—type 1 diabetes mellitus	0.00171	0.00359	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.0017	0.00357	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.00158	0.00331	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00158	0.00331	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—IL6—type 1 diabetes mellitus	0.00156	0.00327	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—NOS1—type 1 diabetes mellitus	0.00152	0.00318	CbGpPWpGaD
Nabumetone—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.0015	0.00314	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.0015	0.00313	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.00141	0.00295	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—type 1 diabetes mellitus	0.00138	0.00289	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CXCL10—type 1 diabetes mellitus	0.00138	0.00288	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.00137	0.00287	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.00133	0.00277	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.00132	0.00276	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00128	0.00269	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.00125	0.00263	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—type 1 diabetes mellitus	0.00123	0.00257	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—type 1 diabetes mellitus	0.00123	0.00256	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.00121	0.00253	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL4—type 1 diabetes mellitus	0.00115	0.0024	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—E2F1—type 1 diabetes mellitus	0.00114	0.00239	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.00111	0.00231	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.00105	0.00219	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.001	0.0021	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.000986	0.00206	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.000961	0.00201	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000954	0.002	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CDK4—type 1 diabetes mellitus	0.000931	0.00195	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—NOS2—type 1 diabetes mellitus	0.000905	0.00189	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—type 1 diabetes mellitus	0.000892	0.00187	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CD4—type 1 diabetes mellitus	0.000879	0.00184	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.000877	0.00184	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000834	0.00175	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.000782	0.00164	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000777	0.00163	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000775	0.00162	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000746	0.00156	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000744	0.00156	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000741	0.00155	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.000715	0.0015	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IFNG—type 1 diabetes mellitus	0.000694	0.00145	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000675	0.00141	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000633	0.00133	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	0.000619	0.0013	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	0.000617	0.00129	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—type 1 diabetes mellitus	0.000616	0.00129	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HBA2—type 1 diabetes mellitus	0.000591	0.00124	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.000577	0.00121	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	0.000568	0.00119	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000567	0.00119	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000567	0.00119	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000555	0.00116	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000546	0.00114	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.00054	0.00113	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.00054	0.00113	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000536	0.00112	CbGpPWpGaD
Nabumetone—PTGS2—Disease—G6PC2—type 1 diabetes mellitus	0.000526	0.0011	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000482	0.00101	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	0.000471	0.000987	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	0.000469	0.000982	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.000458	0.000959	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	0.000449	0.00094	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000441	0.000923	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.00042	0.000879	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000382	0.0008	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000381	0.000797	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	0.000362	0.000758	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000321	0.000673	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000321	0.000671	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	0.000319	0.000668	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000305	0.000639	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	0.000305	0.000637	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000303	0.000635	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	0.000302	0.000633	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000302	0.000632	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	0.000301	0.000629	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000295	0.000618	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOC3—type 1 diabetes mellitus	0.000285	0.000596	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IAPP—type 1 diabetes mellitus	0.000285	0.000596	CbGpPWpGaD
Nabumetone—PTGS2—Disease—B2M—type 1 diabetes mellitus	0.000273	0.000572	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000272	0.000569	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000265	0.000555	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000255	0.000534	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.00025	0.000522	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	0.00024	0.000502	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	0.000239	0.000499	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	0.000235	0.000492	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000234	0.00049	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS1—type 1 diabetes mellitus	0.000229	0.00048	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000216	0.000453	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000216	0.000452	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	0.000215	0.000449	CbGpPWpGaD
Nabumetone—PTGS2—Disease—VAV1—type 1 diabetes mellitus	0.000208	0.000436	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	0.000199	0.000417	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	0.000187	0.000391	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD86—type 1 diabetes mellitus	0.000182	0.00038	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000171	0.000358	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	0.000164	0.000343	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CCR5—type 1 diabetes mellitus	0.000161	0.000337	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	0.000158	0.000331	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	0.000157	0.000329	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000144	0.000302	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—type 1 diabetes mellitus	0.000137	0.000286	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	0.000136	0.000284	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	0.000135	0.000283	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000133	0.000278	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD80—type 1 diabetes mellitus	0.000133	0.000277	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—INS—type 1 diabetes mellitus	0.000132	0.000277	CbGpPWpGaD
Nabumetone—PTGS2—Disease—INS—type 1 diabetes mellitus	0.000125	0.000262	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000122	0.000256	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	0.000121	0.000254	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	0.000116	0.000243	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TYK2—type 1 diabetes mellitus	0.000112	0.000234	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—type 1 diabetes mellitus	0.00011	0.00023	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	0.000106	0.000221	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—INS—type 1 diabetes mellitus	0.000105	0.00022	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—type 1 diabetes mellitus	0.000101	0.000212	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	9.62e-05	0.000201	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	9.2e-05	0.000193	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	8.94e-05	0.000187	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—type 1 diabetes mellitus	7.84e-05	0.000164	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGFR—type 1 diabetes mellitus	7.12e-05	0.000149	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	5.94e-05	0.000124	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—type 1 diabetes mellitus	5.47e-05	0.000115	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	5.44e-05	0.000114	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	5.21e-05	0.000109	CbGpPWpGaD
